Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael J. Kelley"'
Autor:
Leah L. Zullig, Whitney Raska, Gina McWhirter, Scott E. Sherman, Danil Makarov, Daniel Becker, Heather A. King, John Pura, Amy S. Jeffreys, Susanne Danus, Vida Passero, Karen M. Goldstein, Michael J. Kelley
Publikováno v:
JCO Oncology Practice. 19:e504-e510
PURPOSE: As the largest integrated health care system in the United States, the Veterans Health Administration (VA) is a leader in telehealth-delivered care. All 10 million Veterans cared for within the VA are eligible for telehealth. The VA cares fo
Autor:
Jeffrey W. Shevach, Lisa B. Aiello, Julie A. Lynch, Jeffrey Petersen, Lori Hoffman-Hogg, Deborah Hartzfeld, Margaret Lundquist, Michael J. Kelley, Maren T. Scheuner, Robert Montgomery, Nevena Damjanov, Kyle Robinson, Yu-Ning Wong, Darshana Jhala, Ravi B. Parikh, Kara N. Maxwell
Publikováno v:
JCO Oncology Practice.
PURPOSE Telegenetics services can expand access to guideline-recommended cancer genetic testing. However, access is often not distributed equitably to all races and ethnicities. We evaluated the impact of an on-site nurse-led cancer genetics service
Autor:
Pradeep J. Poonnen, Bradley J. Hintze, Jenna L Armstrong, David Winski, Dilhan Weeraratne, Michael J. Kelley, Meghan Price, David Brotman, Gretchen Purcell Jackson, Vishal Vashistha, Jane L. Snowdon
Publikováno v:
JCO Oncology Practice. 17:e1012-e1020
PURPOSE: Next-generation sequencing (NGS) gene panels are frequently completed for patients with advanced non–small-cell lung cancer (NSCLC). Patients with highly actionable gene variants have improved outcomes and reduced toxicities with the use o
Autor:
Bates JS; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC., Piccolo J; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC., Crandall B; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC., Kelley MJ; Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 676-677. Date of Electronic Publication: 2023 Jun 30.